|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128.74 USD | +1.96% |
|
+3.57% | +21.62% |
| 07-21 | Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials | RE |
| 07-17 | GSK stops development of chronic cough drug after late-stage trial miss | RE |
Insider Transaction History
Latest insider transactions for Merck & Co., Inc.
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 30/06/26 | Other | Director | 63 | 125.37 | 7.9K | 0.0000% | ||
| 30/06/26 | Other | Director | 233 | 125.37 | 29.21K | 0.0000% | ||
| 30/06/26 | Other | Director | 126 | 125.37 | 15.8K | 0.0000% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 29/05/26 | Other | Director | 1,853 | 114.70 | 213K | 0.0001% | ||
| 05/05/26 | Other | Executive/Senior Manager | 46,855 | 111.38 | 5.22M | 0.0019% | ||
| 05/05/26 | Other | Executive/Senior Manager | 78,092 | 111.38 | 8.7M | 0.0032% | ||
| 05/05/26 | Other | Executive/Senior Manager | 41,649 | 111.38 | 4.64M | 0.0017% | ||
| 05/05/26 | Other | Public Communications Manager | 26,030 | 111.38 | 2.9M | 0.0011% | ||
| 05/05/26 | Other | Chief Executive Officer | 187,421 | 111.38 | 20.87M | 0.0076% | ||
| 05/05/26 | Other | Controller/Auditor | 7,343 | 111.38 | 818K | 0.0003% | ||
| 05/05/26 | Free | EVP, Specialty, Pharma, & ID | 77,000 | 111.38 | 8.58M | 0.0031% | ||
| 05/05/26 | Other | EVP,Chief Info&Digital Officer | 18,222 | 111.38 | 2.03M | 0.0007% | ||
| 05/05/26 | Other | Head of Human Resources | 31,237 | 111.38 | 3.48M | 0.0013% | ||
| 05/05/26 | Other | General Counsel | 47,376 | 111.38 | 5.28M | 0.0019% | ||
| 05/05/26 | Other | Chief Financial Officer | 62,474 | 111.38 | 6.96M | 0.0025% | ||
| 05/05/26 | Other | EVP & Pres. MMD | 29,155 | 111.38 | 3.25M | 0.0012% | ||
| 02/05/26 | Fiscal year | EVP & Pres. MMD | 1,263 | 112.16 | 79.75K | 0.0001% | ||
| 02/05/26 | Fiscal year | Controller/Auditor | 898 | 112.16 | 57.76K | 0.0000% | ||
| 01/05/26 | Other | EVP & Pres. MMD | 26,178 | - | - | 0.0011% | ||
| 29/04/26 | Fiscal year | Chief Executive Officer | 33,151 | 110.03 | 2.18M | 0.0013% | ||
| 29/04/26 | Fiscal year | Executive/Senior Manager | 3,433 | 110.03 | 226K | 0.0001% | ||
| 29/04/26 | Fiscal year | Executive/Senior Manager | 6,277 | 110.03 | 414K | 0.0003% | ||
| 29/04/26 | Fiscal year | Executive/Senior Manager | 6,324 | 110.03 | 410K | 0.0003% | ||
| 29/04/26 | Fiscal year | Executive/Senior Manager | 11,770 | 110.03 | 775K | 0.0005% | ||
| 29/04/26 | Fiscal year | Chief Technology Officer | 3,433 | 110.03 | 226K | 0.0001% | ||
| 29/04/26 | Fiscal year | Head of Human Resources | 32,728 | 110.82 | 2.14M | 0.0013% | ||
| 29/04/26 | Fiscal year | Public Communications Manager | 4,903 | 110.03 | 323K | 0.0002% | ||
| 29/04/26 | Fiscal year | General Counsel | 7,356 | 110.03 | 485K | 0.0003% | ||
| 29/04/26 | Fiscal year | Chief Financial Officer | 9,808 | 110.03 | 646K | 0.0004% | ||
| 31/03/26 | Other | Director | 405 | - | - | 0.0000% | ||
| 31/03/26 | Other | Director | 68 | - | - | 0.0000% | ||
| 31/03/26 | Other | Director | 249 | - | - | 0.0000% | ||
| 12/02/26 | Sell | Public Communications Manager | 10,000 | 121.46 | 1.21M | 0.0004% | ||
| 10/02/26 | Sell | Executive/Senior Manager | 10,235 | 117.52 | 1.2M | 0.0004% | ||
| 09/02/26 | Sell | Public Communications Manager | 10,000 | 118.41 | 1.18M | 0.0004% | ||
| 09/02/26 | Fiscal year | General Counsel | 364,719 | 119.15 | 28.97M | 0.0147% | ||
| 06/02/26 | Sell | President, U.S. Market | 15,000 | 121.87 | 1.83M | 0.0006% | ||
| 06/02/26 | Fiscal year | EVP,Chief Info&Digital Officer | 15,000 | 99.76 | 998K | 0.0006% | ||
| 06/02/26 | Sell | Executive/Senior Manager | 37,685 | 120.92 | 4.56M | 0.0015% | ||
- Stock Market
- Stocks
- MRK Stock
- Company Merck & Co., Inc.
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















